ArticleAmerican journal of hematology2022
Adoptive transfer of functional SARS-COV-2-specific immunity from donor graft to hematopoietic stem cell transplant recipients.
Abstract readLetter
In one paragraph
Article in American journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis.American journal of hematology · 2023Article
- Allogeneic hematopoietic stem cell transplantation in the COVID-19 era.Frontiers in immunology · 2023Review
- Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.Frontiers in immunology · 2023Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Corinna La RosaDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.ORCID 0000-0002-5258-5720
Flavia ChiuppesiDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Yoonsuh ParkDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Ketevan GendzekhadzeDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Qiao ZhouDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Katelyn FairclothDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Teodora KaltchevaDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Daisy JohnsonDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Sandra Ortega FranciscoDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Idoroenyi AmanamDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.ORCID 0000-0003-4819-4628
Salman OtoukeshDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.ORCID 0000-0002-7782-8805
Vinod A PullarkatDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.ORCID 0000-0001-9129-3424
Ryotaro NakamuraDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.ORCID 0000-0002-9082-0680
Don J DiamondDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Stephen J FormanDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Monzr M Al MalkiDepartment of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.ORCID 0000-0001-8226-471X
Funding
Transplant for Lymphoma:Therapy-Related LeukemiaP50CA107399 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI FORMAN, STEPHEN J, KWAK, LARRY W · 2004 to 2022
$35.5MCytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)U01AI163090 · NIAID · UNIVERSITY OF WASHINGTON · PI Don J Diamond, Cynthia E Fisher · 2021 to 2026
$17.4MOncology Research Career Development ProgramK12CA001727 · NCI · CITY OF HOPE NATIONAL MEDICAL CENTER · PI MORTIMER, JOANNE E. · 1992 to 2024
$14.6MProject 3: Mapping the Evolution of Chronic Transplant Injury in the Context of CMV InfectionU19AI128913 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LANIER, LEWIS LEE · 2017 to 2021
$11.2MCMVPepVax to Protect HCT Recipients from Cytomegalovirus InfectionR01CA181045 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI DIAMOND, DON J · 2014 to 2018
$3.6MNCI NIH HHS K12 CA001727NCI NIH HHS P50 CA107399NCI NIH HHS R01 CA181045NIAID NIH HHS U01 AI163090NIAID NIH HHS U19 AI128913
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAdoptive TransferHumansSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.